{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:34:54Z","timestamp":1792686894440,"version":"4.5.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Secondary diabetes mellitus (DM) in secretory pheochromocytomas and paragangliomas (PPGLs) is encountered in up to 50% of cases, with its presentation ranging from mild, insulin resistant forms to profound insulin deficiency states, such as diabetic ketoacidosis and hyperglycemic hyperosmolar state. PPGLs represent hypermetabolic states, in which adrenaline and noradrenaline induce insulin resistance in target tissues characterized by aerobic glycolysis, excessive lipolysis, altered adipokine expression, subclinical inflammation, as well as enhanced gluconeogenesis and glucogenolysis. These effects are mediated both directly, upon adrenergic receptor stimulation, and indirectly, via increased glucagon secretion. Impaired insulin secretion is the principal pathogenetic mechanism of secondary DM in this setting; yet, this is relevant for tumors with adrenergic phenotype, arising from direct inhibitory actions in beta pancreatic cells and incretin effect impairment. In contrast, insulin secretion might be enhanced in tumors with noradrenergic phenotype. This dimorphic effect might correspond to two distinct glycemic phenotypes, with predominant insulin resistance and insulin deficiency respectively. Secondary DM improves substantially post-surgery, with up to 80% remission rate. The fact that surgical treatment of PPGLs restores insulin sensitivity and secretion at greater extent compared to alpha and beta blockade, implies the existence of further, non-adrenergic mechanisms, possibly involving other hormonal co-secretion by these tumors. DM management in PPGLs is scarcely studied. The efficacy and safety of newer anti-diabetic medications, such as glucagon-like peptide 1 receptor agonists and sodium glucose cotransporter 2 inhibitors (SGLT2is), as well as potential disease-modifying roles of metformin and SGLT2is warrant further investigation in future studies.<\/jats:p>","DOI":"10.1007\/s12020-023-03492-7","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T19:01:56Z","timestamp":1695236516000},"page":"467-479","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Secondary diabetes mellitus in pheochromocytomas and paragangliomas"],"prefix":"10.1007","volume":"82","author":[{"given":"Melpomeni","family":"Moustaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0651-1376","authenticated-orcid":false,"given":"Stavroula A.","family":"Paschou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Vakali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi","family":"Xekouki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Ntali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evanthia","family":"Kassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melpomeni","family":"Peppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Psaltopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinella","family":"Tzanela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andromachi","family":"Vryonidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,20]]},"reference":[{"key":"3492_CR1","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JWM Lenders","year":"2014","unstructured":"J.W.M. Lenders, Q.Y. Duh, G. Eisenhofer, A.P. Gimenez-Roqueplo, S.K.G. Grebe, M.H. Murad, M. Naruse, K. Pacak, W.F. Young, Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99, 1915\u20131942 (2014). https:\/\/doi.org\/10.1210\/jc.2014-1498","journal-title":"J Clin Endocrinol Metab"},{"key":"3492_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1210\/endrev\/bnab019","volume":"43","author":"S N\u00f6lting","year":"2022","unstructured":"S. N\u00f6lting, N. Bechmann, D. Taieb, F. Beuschlein, M. Fassnacht, M. Kroiss, G. Eisenhofer, A. Grossman, K. Pacak, Personalized Management of Pheochromocytoma and Paraganglioma. Endocr Rev 43, 199\u2013239 (2022). https:\/\/doi.org\/10.1210\/endrev\/bnab019","journal-title":"Endocr Rev"},{"key":"3492_CR3","doi-asserted-by":"publisher","unstructured":"A.R. Al Subhi, V. Boyle, M.S. Elston, Systematic review: incidence of pheochromocytoma and paraganglioma over 70 years. J Endocr Soc. 6, (2022). https:\/\/doi.org\/10.1210\/jendso\/bvac105","DOI":"10.1210\/jendso\/bvac105"},{"key":"3492_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/5584_2016_76","volume":"956","author":"PTK Gunawardane","year":"2016","unstructured":"P.T.K. Gunawardane, A. Grossman, Phaeochromocytoma and paraganglioma. Adv Exp Med Biol 956, 239\u2013259 (2016). https:\/\/doi.org\/10.1007\/5584_2016_76","journal-title":"Adv Exp Med Biol"},{"key":"3492_CR5","doi-asserted-by":"publisher","first-page":"S508","DOI":"10.1097\/01.CCM.0000278047.06965.20","volume":"35","author":"E Barth","year":"2007","unstructured":"E. Barth, G. Albuszies, K. Baumgart, M. Matejovic, U. Wachter, J. Vogt, P. Radermacher, E. Calzia, Glucose metabolism and catecholamines. Crit Care Med 35, S508\u2013S518 (2007). https:\/\/doi.org\/10.1097\/01.CCM.0000278047.06965.20","journal-title":"Crit Care Med"},{"key":"3492_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s42000-019-00147-z","volume":"19","author":"KJ Ioakim","year":"2020","unstructured":"K.J. Ioakim, G.I. Sydney, S.A. Paschou, Glucose metabolism disorders in patients with adrenal gland disorders: pathophysiology and management. Hormones 19, 135\u2013143 (2020). https:\/\/doi.org\/10.1007\/s42000-019-00147-z","journal-title":"Hormones"},{"key":"3492_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ando.2020.01.001","volume":"81","author":"A Elenkova","year":"2020","unstructured":"A. Elenkova, J. Matrozova, V. Vasilev, R. Robeva, S. Zacharieva, Prevalence and progression of carbohydrate disorders in patients with pheochromocytoma\/paraganglioma: retrospective single-center study. Ann Endocrinol 81, 3\u201310 (2020). https:\/\/doi.org\/10.1016\/j.ando.2020.01.001","journal-title":"Ann Endocrinol"},{"key":"3492_CR8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.4103\/aam.aam_13_20","volume":"20","author":"S Derrou","year":"2021","unstructured":"S. Derrou, T. Bouziane, H. Salhi, H. El Ouahabi, Pheochromocytoma and glucoregulation disorders. Ann Afr Med 20, 42\u201345 (2021). https:\/\/doi.org\/10.4103\/aam.aam_13_20","journal-title":"Ann Afr Med"},{"key":"3492_CR9","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1245\/s10434-016-5701-6","volume":"24","author":"T Beninato","year":"2017","unstructured":"T. Beninato, W.P. Kluijfhout, F.T. Drake, J. Lim, J.S. Kwon, M. Xiong, W.T. Shen, J.E. Gosnell, C. Liu, I. Suh, Q.Y. Duh, Resection of pheochromocytoma improves diabetes mellitus in the majority of patients. Ann Surg Oncol 24, 1208\u20131213 (2017). https:\/\/doi.org\/10.1245\/s10434-016-5701-6","journal-title":"Ann Surg Oncol"},{"key":"3492_CR10","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1016\/j.dsx.2020.10.030","volume":"14","author":"S Khatiwada","year":"2020","unstructured":"S. Khatiwada, S. Agarwal, D. Kandasamy, V.P. Jyotsna, R. Kumar, V. Kumar Bansal, R.M. Pandey, N. Gupta, N. Tandon, Diabetes mellitus in pheochromocytoma and paraganglioma: prevalence, dynamics of insulin secretion\/sensitivity and predictors of remission. Diabetes Metab Syndr Clin Res Rev. 14, 2169\u20132175 (2020). https:\/\/doi.org\/10.1016\/j.dsx.2020.10.030","journal-title":"Diabetes Metab Syndr Clin Res Rev."},{"key":"3492_CR11","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.asjsur.2019.01.012","volume":"42","author":"ZH Liu","year":"2019","unstructured":"Z.H. Liu, L. Zhou, L. Lin, De, T. Chen, Q.Y. Jiang, Z.H. Liu, K.J. Wang, Y.C. Zhu, H. Li, Y. Ren, Will the resection of pheochromocytoma improve preoperative diabetes mellitus. Asian J Surg 42, 990\u2013994 (2019). https:\/\/doi.org\/10.1016\/j.asjsur.2019.01.012","journal-title":"Asian J Surg"},{"key":"3492_CR12","doi-asserted-by":"publisher","unstructured":"D.C.D. Hope, J.M. Palan Unusual presentation of phaeochromocytoma. BMJ Case Rep (2016). https:\/\/doi.org\/10.1136\/bcr-2016","DOI":"10.1136\/bcr-2016"},{"key":"3492_CR13","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jdiacomp.2007.02.006","volume":"22","author":"S Douma","year":"2008","unstructured":"S. Douma, K. Petidis, N. Kartali, K. Mahera, C. Sabanis, C. Zamboulis, Pheochromocytoma presenting as diabetic ketoacidosis. J Diabetes Complicat. 22, 295\u2013296 (2008). https:\/\/doi.org\/10.1016\/j.jdiacomp.2007.02.006","journal-title":"J Diabetes Complicat."},{"key":"3492_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0168-8227(01)00261-3","volume":"54","author":"C Ishii","year":"2001","unstructured":"C. Ishii, K. Lnoue, K. Negishi, N. Tane, T. Awata, S. Katayama, Diabetic ketoacidosis in a case of pheochromocytoma. Diabetes Res Clin Pract 54, 137\u2013142 (2001)","journal-title":"Diabetes Res Clin Pract"},{"key":"3492_CR15","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s11739-015-1217-5","volume":"10","author":"IS Lee","year":"2015","unstructured":"I.S. Lee, T.W. Lee, C.J. Chang, Y.M. Chien, T.I. Lee, Pheochromocytoma presenting as hyperglycemic hyperosmolar syndrome and unusual fever. Intern Emerg Med 10, 753\u2013755 (2015). https:\/\/doi.org\/10.1007\/s11739-015-1217-5","journal-title":"Intern Emerg Med"},{"key":"3492_CR16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3949\/ccjm.59.4.423","volume":"59","author":"C Kii","year":"1992","unstructured":"C. Kii, E.R. Edelman, C.A. Stuenkel, J.D. Rutherford, G.H. Williams, Diabetic ketoacidosis associated with pheochromocytoma. Cleve Clin J Med 59, 423\u2013427 (1992)","journal-title":"Cleve Clin J Med"},{"key":"3492_CR17","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.2169\/internalmedicine.55.7071","volume":"55","author":"H Hirai","year":"2016","unstructured":"H. Hirai, S. Midorikawa, S. Suzuki, H. Sasano, T. Watanabe, H. Satoh, Somatostatin-secreting pheochromocytoma mimicking insulin-dependent diabetes mellitus. Intern Med 55, 2985\u20132991 (2016). https:\/\/doi.org\/10.2169\/internalmedicine.55.7071","journal-title":"Intern Med"},{"key":"3492_CR18","doi-asserted-by":"publisher","unstructured":"B.P. Wang, L.L. Yang, H. Wang, Q. He, Z.S. Ma, Y. Lin, C.X. Jiang, H.R. Sun, M. Liu, An unusual case of ectopic corticotrophin-releasing hormone syndrome caused by an adrenal noncatecholamine-secreting pheochromocytoma: a case report. BMC Endocr Disord 18, (2018). https:\/\/doi.org\/10.1186\/s12902-018-0269-8","DOI":"10.1186\/s12902-018-0269-8"},{"key":"3492_CR19","doi-asserted-by":"publisher","unstructured":"S. Zaman, B. Patel, P. Glynne, M. Vanderpump, A. Alsafi, S. Khan, R. Flora, F. Palazzo, F. Wernig, A rare cause of severe Cushing\u2019s syndrome. Endocrinol Diabetes Metab Case Rep 2020, (2020). https:\/\/doi.org\/10.1530\/EDM-20-0011","DOI":"10.1530\/EDM-20-0011"},{"key":"3492_CR20","doi-asserted-by":"publisher","unstructured":"S.F.W.M. Hatta, L. Lekkakou, A. Viswananth, H. Buch, Ectopic adrenocorticotrophic hormone syndrome (EAS) with phaeochromocytoma: a challenging endocrine case with a happy ending. BMJ Case Rep 12, (2019). https:\/\/doi.org\/10.1136\/bcr-2019-230636","DOI":"10.1136\/bcr-2019-230636"},{"key":"3492_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.14310\/horm.2002.1184","volume":"2","author":"E Diamanti-Kandarakis","year":"2003","unstructured":"E. Diamanti-Kandarakis, E. Zapanti, M.-H. Peridis, P. Ntavos, G. Mastorakos, Insulin resistance in pheochromocytoma improves more by surgical rather than by medical treatment. Hormones. 2, 61\u201366 (2003)","journal-title":"Hormones."},{"key":"3492_CR22","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1177\/0300060519855179","volume":"47","author":"N Morita","year":"2019","unstructured":"N. Morita, T. Hosaka, Y. Yamazaki, K. Takahashi, H. Sasano, H. Ishida, Abnormal glucose tolerance in a patient with pheochromocytoma and ACTH-independent subclinical Cushing\u2019s syndrome involving the same adrenal gland. J Int Med Res 47, 3360\u20133370 (2019). https:\/\/doi.org\/10.1177\/0300060519855179","journal-title":"J Int Med Res"},{"key":"3492_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1507\/endocrj.EJ18-0407","volume":"66","author":"I Abe","year":"2019","unstructured":"I. Abe, H. Fujii, H. Ohishi, K. Sugimoto, M. Minezaki, M. Nakagawa, S. Takahara, T. Kudo, M. Abe, K. Ohe, T. Yanase, K. Kobayashi, Differences in the actions of adrenaline and noradrenaline with regard to glucose intolerance in patients with pheochromocytoma. Endocr J 66, 187\u2013192 (2019)","journal-title":"Endocr J"},{"key":"3492_CR24","doi-asserted-by":"publisher","unstructured":"O. Petr\u00e1k, D. Haluz\u00edkov\u00e1, J. Kl\u00edmov\u00e1, M. Z\u00edtek, R. Holaj, D. Michalsk\u00fd, K. Nov\u00e1k, R. Petr\u00e1kov\u00e1-Dole\u017ealov\u00e1, J. Kvasni\u010dka, T.M.P.N. Nguyen, Z. Kr\u00e1tk\u00e1, M. Matoulek, J. Widimsk\u00fd, T. Zelinka, Hypermetabolism and substrate utilization rates in pheochromocytoma and functional paraganglioma. Biomedicines. 10, (2022). https:\/\/doi.org\/10.3390\/biomedicines10081980","DOI":"10.3390\/biomedicines10081980"},{"key":"3492_CR25","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1210\/jc.2003-030000","volume":"88","author":"TD Wiesner","year":"2003","unstructured":"T.D. Wiesner, M. Bl\u00fcher, M. Windgassen, R. Paschke, Improvement of insulin sensitivity after adrenalectomy in patients with pheochromocytoma. J Clin Endocrinol Metab 88, 3632\u20133636 (2003). https:\/\/doi.org\/10.1210\/jc.2003-030000","journal-title":"J Clin Endocrinol Metab"},{"key":"3492_CR26","doi-asserted-by":"publisher","unstructured":"I. Abe, F. Islam, A.K.Y. Lam, Glucose intolerance on phaeochromocytoma and paraganglioma\u2014the current understanding and clinical perspectives. Front Endocrinol. 11, (2020). https:\/\/doi.org\/10.3389\/fendo.2020.593780","DOI":"10.3389\/fendo.2020.593780"},{"key":"3492_CR27","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1172\/JCI109718","volume":"65","author":"DC Deibert","year":"1980","unstructured":"D.C. Deibert, R.A. Defronzo, Epinephrine-induced insulin resistance in man. J Clin Invest 65, 717\u2013721 (1980)","journal-title":"J Clin Invest"},{"key":"3492_CR28","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1172\/JCI109714","volume":"65","author":"RA Rizza","year":"1980","unstructured":"R.A. Rizza, P.E. Cryer, M.W. Haymond, J.E. Gerich, Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man. J Clin Invest 65, 682\u2013689 (1980)","journal-title":"J Clin Invest"},{"key":"3492_CR29","doi-asserted-by":"publisher","unstructured":"M. Murabayashi, M. Daimon, H. Murakami, T. Fujita, E. Sato, J. Tanabe, Y. Matsuhashi, S. Takayasu, M. Yanagimachi, K. Terui, K. Kageyama, I. Tokuda, K. Sawada, K. Ihara. Association between higher urinary normetanephrine and insulin resistance in a Japanese population. PLoS One. 15, (2020). https:\/\/doi.org\/10.1371\/journal.pone.0228787","DOI":"10.1371\/journal.pone.0228787"},{"key":"3492_CR30","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/0006-291X(92)91249-P","volume":"187","author":"A Bonen","year":"1992","unstructured":"A. Bonen, L.A. Megeney, S.C. Mccarthy, J.C. Mcdermottt, M.H. Tan, Epinephrine administration stimulates GLUT4 translocation but reduces glucose transport in muscle. Biochem Biophys Res Commun 187, 685\u2013691 (1992)","journal-title":"Biochem Biophys Res Commun"},{"key":"3492_CR31","doi-asserted-by":"publisher","first-page":"R666","DOI":"10.1152\/ajpregu.00285.2018","volume":"316","author":"S Mukaida","year":"2019","unstructured":"S. Mukaida, M. Sato, A.I. \u00d6berg, N. Dehvari, J.M. Olsen, M. Kocan, M.L. Halls, J. Merlin, A.L. Sandstr\u00f6m, R.I. Csikasz, B.A. Evans, R.J. Summers, D.S. Hutchinson, T. Bengtsson, BRL37344 stimulates GLUT4 translocation and glucose uptake in skeletal muscle via \u03b22-adrenoceptors without causing classical receptor desensitization. Am J Physiol Regul Integr Comp Physiol 316, R666\u2013R677 (2019). https:\/\/doi.org\/10.1152\/ajpregu.00285.2018","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"3492_CR32","doi-asserted-by":"publisher","first-page":"E700","DOI":"10.1152\/ajpendo.1998.274.4.E700","volume":"274","author":"X-X Han","year":"1998","unstructured":"X.-X. Han, A. Bonen, Epinephrine translocates GLUT-4 but inhibits insulin-stimulated glucose transport in rat muscle. Am J Physiol Endocrinol Metab 274, E700\u2013E707 (1998)","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3492_CR33","first-page":"E430","volume":"260","author":"I Raz","year":"1991","unstructured":"I. Raz, A. Katz, M.K. Spencer, Epinephrine inhibits insulin-mediated glycogenesis but enhances glycolysis in human skeletal muscle. Am J Physiol 260, E430\u2013E435 (1991)","journal-title":"Am J Physiol"},{"key":"3492_CR34","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s001250051093","volume":"41","author":"M Niklasson","year":"1998","unstructured":"M. Niklasson, A. Holm\u00e4ng, P. L\u00f6nnroth, Induction of rat muscle insulin resistance by epinephrine is accompanied by increased interstitial glucose and lactate concentrations. Diabetologia. 41, 1467\u20131473 (1998)","journal-title":"Diabetologia."},{"key":"3492_CR35","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1080\/10799893.2016.1193522","volume":"37","author":"T Shi","year":"2017","unstructured":"T. Shi, R.S. Papay, D.M. Perez, The role of \u03b11-adrenergic receptors in regulating metabolism: increased glucose tolerance, leptin secretion and lipid oxidation. J Recept Signal Transduct Res 37, 124\u2013132 (2017). https:\/\/doi.org\/10.1080\/10799893.2016.1193522","journal-title":"J Recept Signal Transduct Res"},{"key":"3492_CR36","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1111\/bph.v176.14\/issuetoc","volume":"176","author":"J Akinaga","year":"2019","unstructured":"J. Akinaga, J.A. Garc\u00edas\u00e1inz, A.S. Pupo, Updates in the function and regulation of \u03b11 -adrenoceptors. Br J Pharmacol 176, 2343\u20132357 (2019). https:\/\/doi.org\/10.1111\/bph.v176.14\/issuetoc","journal-title":"Br J Pharmacol"},{"key":"3492_CR37","doi-asserted-by":"publisher","first-page":"e1982","DOI":"10.1371\/journal.pone.0019282","volume":"6","author":"V Goral","year":"2011","unstructured":"V. Goral, Y. Jin, H. Sun, A.M. Ferrie, Q. Wu, Y. Fang, Agonist-directed desensitization of the \u03b22-adrenergic receptor. PLoS One 6, e1982 (2011). https:\/\/doi.org\/10.1371\/journal.pone.0019282","journal-title":"PLoS One"},{"key":"3492_CR38","doi-asserted-by":"publisher","first-page":"e4551","DOI":"10.7759\/cureus.4551","volume":"11","author":"JA Ronen","year":"2019","unstructured":"J.A. Ronen, M. Gavin, M.D. Ruppert, A.N. Peiris, Glycemic disturbances in pheochromocytoma and paraganglioma. Cureus 11, e4551 (2019). https:\/\/doi.org\/10.7759\/cureus.4551","journal-title":"Cureus"},{"key":"3492_CR39","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1113\/jphysiol.1951.sp004679","volume":"15","author":"AG Bearn","year":"1951","unstructured":"A.G. Bearn, B. Billing, S. Sherlock, The effect of adrenaline and noradrenaline on hepatic blood flow and splanchnic carbohydrate metabolism in man. J Physiol 15, 430\u2013474 (1951)","journal-title":"J Physiol"},{"key":"3492_CR40","doi-asserted-by":"publisher","unstructured":"M. Tomoyasu, Y. Mori, A. Fukase, H. Kushima, T. Hirano Pheochromocytoma presenting with severe hyperglycemia and metabolic acidosis following intra-articular glucocorticoid administration: a case report. J Med Case Rep. 13, (2019), https:\/\/doi.org\/10.1186\/s13256-018-1945-z","DOI":"10.1186\/s13256-018-1945-z"},{"key":"3492_CR41","doi-asserted-by":"publisher","first-page":"17450","DOI":"10.1073\/pnas.1410530111","volume":"111","author":"GR Mullins","year":"2014","unstructured":"G.R. Mullins, L. Wang, V. Raje, S.G. Sherwood, R.C. Grande, S. Boroda, J.M. Eaton, S. Blancquaert, P.P. Roger, N. Leitinger, T.E. Harris, Catecholamine-induced lipolysis causes mTOR complex dissociation and inhibits glucose uptake in adipocytes. Proc Natl Acad Sci USA 111, 17450\u201317455 (2014). https:\/\/doi.org\/10.1073\/pnas.1410530111","journal-title":"Proc Natl Acad Sci USA"},{"key":"3492_CR42","doi-asserted-by":"publisher","first-page":"13685","DOI":"10.1016\/S0021-9258(17)43971-8","volume":"258","author":"A Kashiwagi","year":"1983","unstructured":"A. Kashiwagi, T.P. Huecksteadt, J.E. Foleys, The regulation of glucose transport by cAMP stimulators via three different mechanisms in rat and human adipocytes\u201d. J Biol Chem 258, 13685\u201313692 (1983)","journal-title":"J Biol Chem"},{"key":"3492_CR43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/BF00935588","volume":"141","author":"SL Macaulay","year":"1994","unstructured":"S.L. Macaulay, A.S.M. Kelada, J. Proietto, Isoproterenol inhibits cyclic AMP-mediated but not insulin-mediated translocation of the GLUT4 glucose transporter isoform. Mol Cell Biochem 141, 27\u201333 (1994)","journal-title":"Mol Cell Biochem"},{"key":"3492_CR44","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.2174\/1381612013397339","volume":"7","author":"CJ De Souza","year":"2001","unstructured":"C.J. De Souza, B.F. Burkey, Beta 3-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans. Curr Pharm Des 7, 1433\u20131449 (2001)","journal-title":"Curr Pharm Des"},{"key":"3492_CR45","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/oby.2002.75","volume":"10","author":"M Boschmann","year":"2002","unstructured":"M. Boschmann, G. Krupp, F.C. Luft, S. Klaus, J. Jordan, In vivo response to 1-adrenoreceptor stimulation in human white adipose tissue. Obes Res 10, 555\u2013558 (2002)","journal-title":"Obes Res"},{"key":"3492_CR46","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.cyto.2010.03.011","volume":"50","author":"A Elenkova","year":"2010","unstructured":"A. Elenkova, J. Matrozova, S. Zacharieva, G. Kirilov, K. Kalinov, Adiponectin - a possible factor in the pathogenesis of carbohydrate metabolism disturbances in patients with pheochromocytoma. Cytokine 50, 306\u2013310 (2010). https:\/\/doi.org\/10.1016\/j.cyto.2010.03.011","journal-title":"Cytokine"},{"key":"3492_CR47","doi-asserted-by":"publisher","unstructured":"A. Babinska, M. Kaszubowski, P. Kmie\u0107, K. Sworczak, Selected adipocytokines in patients with an incidentally discovered pheochromocytoma. Minerva Endocrinol. 45, (2020). https:\/\/doi.org\/10.23736\/S0391-1977.19.03007-4","DOI":"10.23736\/S0391-1977.19.03007-4"},{"key":"3492_CR48","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S0014-5793(01)02960-X","volume":"507","author":"M Fasshauer","year":"2001","unstructured":"M. Fasshauer, J. Klein, S. Neumann, M. Eszlinger, R. Paschke, Adiponectin gene expression is inhibited by \u03b2-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Lett 507, 142\u2013146 (2001)","journal-title":"FEBS Lett"},{"key":"3492_CR49","doi-asserted-by":"publisher","first-page":"442","DOI":"10.5551\/jat.No885","volume":"16","author":"K Isobe","year":"2009","unstructured":"K. Isobe, L. Fu, I. Tatsuno, H. Takahashi, S. Nissato, H. Hara, T. Yashiro, K. Suzukawa, K. Takehoshi, H. Shimano, Y. Kawakami, Adiponectin and adiponectin receptors in human pheochromocytoma. J Atheroscler Thromb 16, 442\u2013447 (2009)","journal-title":"J Atheroscler Thromb"},{"key":"3492_CR50","doi-asserted-by":"publisher","first-page":"319","DOI":"10.33549\/physiolres.931483","volume":"58","author":"L Bo\u0161ansk\u00e1","year":"2009","unstructured":"L. Bo\u0161ansk\u00e1, O. Petr\u00e1k, T. Zelinka, M. Mr\u00e1z, J. Widimsk\u00fd, M. Haluz\u00edk, The effect of pheochromocytoma treatment on subclinical inflammation and endocrine function of adipose tissue. Physiol. Res. 58, 319\u2013325 (2009)","journal-title":"Physiol. Res."},{"key":"3492_CR51","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.3390\/nu14102103","volume":"14","author":"C Vetrani","year":"2022","unstructured":"C. Vetrani, A. Di Nisio, S.A. Paschou, L. Barrea, G. Muscogiuri, C. Graziadio, S. Savastano, A. Colao, From gut microbiota through low-grade inflammation to obesity: key players and potential targets. Nutrients 14, 2103 (2022). https:\/\/doi.org\/10.3390\/nu14102103","journal-title":"Nutrients"},{"key":"3492_CR52","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1210\/clinem\/dgz314","volume":"105","author":"Z Abdul Sater","year":"2020","unstructured":"Z. Abdul Sater, A. Jha, A. Hamimi, A. Mandl, I.R. Hartley, S. Gubbi, M. Patel, M. Gonzales, D. Ta\u00efeb, A.C. Civelek, A.M. Gharib, S. Auh, A.E. O\u2019Mara, K. Pacak, A.M. Cypess, Pheochromocytoma and paraganglioma patients with poor survival often show brown adipose tissue activation. J Clin Endocrinol Metab 105, 1176\u20131185 (2020). https:\/\/doi.org\/10.1210\/clinem\/dgz314","journal-title":"J Clin Endocrinol Metab"},{"key":"3492_CR53","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1172\/JCI110451","volume":"69","author":"L Sacca","year":"1982","unstructured":"L. Sacca, C. Vigorito, M. Cicala, B. Ungaro, R.S. Sherwin, Mechanisms of epinephrine-induced glucose intolerance in normal humans. Role of the splanchnic bed. J Clin Investig 69, 284\u2013293 (1982)","journal-title":"J Clin Investig"},{"key":"3492_CR54","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1210\/jcem-62-5-827","volume":"62","author":"Y Kawai","year":"1986","unstructured":"Y. Kawai, A. Powell, I.J. Arinze, Adrenergic receptors in human liver plasma membranes: predominance of \u03b22- and \u03b11-receptor subtypes. J Clin Endocrinol Metab 62, 827\u2013832 (1986)","journal-title":"J Clin Endocrinol Metab"},{"key":"3492_CR55","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0922-4106(95)90171-X","volume":"289","author":"JA Garcia-Sfiinz","year":"1995","unstructured":"J.A. Garcia-Sfiinz, M.T. Romero-Avila, M.E. Torres-Mfirquez, Characterization of the human liver al-adrenoceptors: predominance of the ala subtype. Eur J Pharmacol 289, 81\u201386 (1995)","journal-title":"Eur J Pharmacol"},{"key":"3492_CR56","doi-asserted-by":"publisher","first-page":"E616","DOI":"10.1152\/ajpendo.1983.245.6.E616","volume":"8","author":"SG Rosen","year":"1983","unstructured":"S.G. Rosen, W.E. Clutter, S.D. Shah, J. Philip Miller, D.M. Bier, P.E. Cryer, Direct a-adrenergic stimulation of hepatic glucose production in human subjects. Am J Physiol Endocrinol Metab 8, E616\u2013E626 (1983)","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3492_CR57","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1152\/ajpendo.00113.2004.-In","volume":"288","author":"L Erraji-Benchekroun","year":"2005","unstructured":"L. Erraji-Benchekroun, D. Couton, C. Postic, I. Borde, J. Gaston, J.-G. Guillet, C. Andr\u00e9, E. Benchekroun, D. Loubna, C. Couton, I. Postic, J. Borde, J.-G. Gaston, C.A. Guillet, Overexpression of \u03b22-adrenergic receptors in mouse liver alters the expression of gluconeogenic and glycolytic enzymes. Am J Physiol Endocrinol Metab 288, 715\u2013722 (2005). https:\/\/doi.org\/10.1152\/ajpendo.00113.2004.-In","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3492_CR58","doi-asserted-by":"publisher","first-page":"999","DOI":"10.4158\/EP171914.RA","volume":"23","author":"B Mesmar","year":"2017","unstructured":"B. Mesmar, S. Poola-Kella, R. Malek, The physiology behind diabetes mellitus in patients with pheochromocytoma: a review of the literature. Endocr Pract 23, 999\u20131005 (2017). https:\/\/doi.org\/10.4158\/EP171914.RA","journal-title":"Endocr Pract"},{"key":"3492_CR59","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00210-003-0858-5","volume":"369","author":"E Vieira","year":"2004","unstructured":"E. Vieira, Y.J. Liu, E. Gylfe, Involvement of \u03b11 and \u03b2-adrenoceptors in adrenaline stimulation of the glucagon-secreting mouse \u03b1-cell. Naunyn Schmiedebergs Arch Pharmacol 369, 179\u2013183 (2004). https:\/\/doi.org\/10.1007\/s00210-003-0858-5","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"3492_CR60","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.2337\/db17-1102","volume":"67","author":"A Hamilton","year":"2018","unstructured":"A. Hamilton, Q. Zhang, A. Salehi, M. Willems, J.G. Knudsen, A.K. Ringgaard, C.E. Chapman, A. Gonzalez-Alvarez, N.C. Surdo, M. Zaccolo, D. Basco, P.R.V. Johnson, R. Ramracheya, G.A. Rutter, A. Galione, P. Rorsman, A.I. Tarasov, Adrenaline stimulates glucagon secretion by Tpc2-Dependent Ca2+ mobilization from acidic stores in pancreatic \u03b1-cells. Diabetes 67, 1128\u20131139 (2018). https:\/\/doi.org\/10.2337\/db17-1102","journal-title":"Diabetes"},{"key":"3492_CR61","doi-asserted-by":"publisher","first-page":"25798","DOI":"10.1016\/S0021-9258(18)35680-1","volume":"267","author":"D Wu","year":"1992","unstructured":"D. Wu, A. Katz, C.-H. Lee, M.I. Simon, Activation of phospholipase C by \u03b11-adrenergic receptors is mediated by the \u03b1 subunits of Gq family. J Biol Chem 267, 25798\u201325802 (1992)","journal-title":"J Biol Chem"},{"key":"3492_CR62","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1210\/jcem-29-7-911","volume":"29","author":"JE Vance","year":"1969","unstructured":"J.E. Vance, K.D. Buchanan, D. O\u2019hara, R.H. Williams, D. Porte, Insulin and glucagon responses in subjects with pheochromocytoma: effect of alpha adrenergic blockade. J Clin Endocrinol 29, 911\u2013916 (1969)","journal-title":"J Clin Endocrinol"},{"key":"3492_CR63","doi-asserted-by":"publisher","first-page":"251","DOI":"10.7326\/0003-4819-71-2-251","volume":"71","author":"JA Colwell","year":"1969","unstructured":"J.A. Colwell, F.A.C.P. Chicago, Inhibition of insulin secretion by catecholamines in pheochromocytoma. Ann Intern Med 71, 251\u2013256 (1969)","journal-title":"Ann Intern Med"},{"key":"3492_CR64","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1210\/jc.2017-00357","volume":"102","author":"H Komada","year":"2017","unstructured":"H. Komada, Y. Hirota, A. So, T. Nakamura, Y. Okuno, H. Fukuoka, G. Iguchi, Y. Takahashi, K. Sakaguchi, W. Ogawa, Insulin secretion and insulin sensitivity before and after surgical treatment of pheochromocytoma or paraganglioma. J Clin Endocrinol Metabol. 102, 3400\u20133405 (2017). https:\/\/doi.org\/10.1210\/jc.2017-00357","journal-title":"J Clin Endocrinol Metabol."},{"key":"3492_CR65","doi-asserted-by":"publisher","unstructured":"O. Petr\u00e1k, J. Kl\u00edmov\u00e1, M. Mr\u00e1z, D. Haluz\u00edkov\u00e1, R.P., Dole\u017ealov\u00e1, H. Kratochv\u00edlov\u00e1, Z. Lacinov\u00e1, K. Nov\u00e1k, D. Michalsk\u00fd, P. Waldauf, R. Holaj, J. Widimsk\u00fd, T. Zelinka, M. Haluz\u00edk Pheochromocytoma with adrenergic biochemical phenotype shows decreased GLP-1 secretion and impaired glucose tolerance. J Clin Endocrinol Metab. 105, (2020). https:\/\/doi.org\/10.1210\/clinem\/dgaa154\/5813460","DOI":"10.1210\/clinem\/dgaa154\/5813460"},{"key":"3492_CR66","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0168-8227(86)80069-9","volume":"2","author":"P Filipponi","year":"1986","unstructured":"P. Filipponi, F. Gregorio, C. Ferrandina, I. Nicoletti, C. Mannarelli, R. Pippi, F. Santeusanio, Alpha-adrenergic system in the modulation of pancreatic A and B cell function in normal rats. Diabetes Res Clin Pract 2, 325\u2013336 (1986)","journal-title":"Diabetes Res Clin Pract"},{"key":"3492_CR67","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1742-7843.2011.00699.x","volume":"108","author":"V Fagerholm","year":"2011","unstructured":"V. Fagerholm, M. Haaparanta, M. Scheinin, \u03b12-adrenoceptor regulation of blood glucose homeostasis. Basic Clin Pharmacol Toxicol 108, 365\u2013370 (2011). https:\/\/doi.org\/10.1111\/j.1742-7843.2011.00699.x","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"3492_CR68","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s001250051467","volume":"43","author":"JC Devedjian","year":"2000","unstructured":"J.C. Devedjian, A. Pujol, C. Cayla, M. George, A. Casellas, H. Paris, F. Bosch, Transgenic mice overexpressing a 2A-adrenoceptors in pancreatic beta-cells show altered regulation of glucose homeostasis. Diabetologia. 43, 899\u2013906 (2000)","journal-title":"Diabetologia."},{"key":"3492_CR69","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1677\/jme.1.01764","volume":"35","author":"X Hu","year":"2005","unstructured":"X. Hu, D. Friedman, S. Hill, R. Caprioli, W. Nicholson, A.C. Powers, L. Hunter, L.E. Limbird, Proteomic exploration of pancreatic islets in mice null for the \u03b12A adrenergic receptor. J Mol Endocrinol 35, 73\u201388 (2005). https:\/\/doi.org\/10.1677\/jme.1.01764","journal-title":"J Mol Endocrinol"},{"key":"3492_CR70","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1016\/s0021-9258(19)77955-1","volume":"263","author":"T Nilsson","year":"1988","unstructured":"T. Nilsson, P. Arkhammar, P. Rorsman, P.O. Berggren, Inhibition of glucose-stimulated insulin release by \u03b12-adrenoceptor activation is parallelled by both a repolarization and a reduction in cytoplasmic free Ca2+ concentration. J Biol Chem 263, 1855\u20131860 (1988). https:\/\/doi.org\/10.1016\/s0021-9258(19)77955-1","journal-title":"J Biol Chem"},{"key":"3492_CR71","doi-asserted-by":"crossref","unstructured":"W.H. Hsu, H. Xiang, A.S. Rajan, A.E. Boyd, Activation of a2-adrenergic receptors decreases Ca2+ influx to inhibit insulin secretion in a hamster \u03b2-cell line: an action mediated by a guanosine triphosphate-binding protein. Endocrinology. 128, 958\u2013964 (1991)","DOI":"10.1210\/endo-128-2-958"},{"key":"3492_CR72","doi-asserted-by":"publisher","first-page":"699","DOI":"10.2337\/db16-1166","volume":"66","author":"K Ito","year":"2017","unstructured":"K. Ito, K. Dezaki, M. Yoshida, H. Yamada, R. Miura, R. Sukma Rita, S. Ookawara, K. Tabei, M. Kawakami, K. Hara, Y. Morishita, T. Yada, M. Kakei, Endogenous \u03b12A-adrenoceptor-operated sympathoadrenergic tones attenuate insulin secretion via cAMP\/TRPM2 signaling. Diabetes. 66, 699\u2013709 (2017)","journal-title":"Diabetes."},{"key":"3492_CR73","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1126\/science.1176827","volume":"327","author":"AH Rosengren","year":"2010","unstructured":"A.H. Rosengren, R. Jokubka, D. Tojjar, C. Granhall, O. Hansson, D.Q. Li, V. Nagaraj, T.M. Reinbothe, J. Tuncel, L. Eliasson, L. Groop, P. Rorsman, A. Salehi, V. Lyssenko, H. Luthman, E. Renstr\u00f6m, Overexpression of Alpha2A-Adrenergic receptors contributes to type 2 diabetes. Science (1979). 327, 217\u2013220 (2010). https:\/\/doi.org\/10.1126\/science.1176827","journal-title":"Science (1979)."},{"key":"3492_CR74","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2337\/diab.36.2.221","volume":"36","author":"S Kawazu","year":"1987","unstructured":"S. Kawazu, M. Suzuki, K. Negishi, J. Ishii, H. Sando, H. Katagiri, Y. Kanazawa, S. Yamanouchi, Y. Akanuma, H. Kajinuma, K. Suzuki, K. Watanabe, T. Itoh, T. Kobayashi, K. Kosaka, Initial phase II clinical studies on midaglizole (DG-5128) a new hypoglycemic agent. Diabetes. 36, 221\u2013226 (1987)","journal-title":"Diabetes."},{"key":"3492_CR75","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/0026-0495(91)90210-N","volume":"40","author":"FJ Ortiz-Alonso","year":"1991","unstructured":"F.J. Ortiz-Alonso, W.H. Herman, B.J. Gertz, V.C. Williams, M.J. Smith, J.B. Halter, Effect of an oral a2-adrenergic blocker (MK-912) on pancreatic islet function in non-insulin-dependent diabetes mellitus. Metabolism. 40, 1160\u20131167 (1991)","journal-title":"Metabolism."},{"key":"3492_CR76","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1677\/joe.0.1110263","volume":"111","author":"JM Fyles","year":"1986","unstructured":"J.M. Fyles, M.A. Cawthorne, S.L. Howell, The characteristics of \u03b2-adrenergic binding sites on pancreatic islets of Langerhans. J Endocr 111, 263\u2013270 (1986)","journal-title":"J Endocr"},{"key":"3492_CR77","doi-asserted-by":"publisher","first-page":"470","DOI":"10.5114\/aoms.2016.64131","volume":"13","author":"SZ Safi","year":"2017","unstructured":"S.Z. Safi, R. Qvist, G. Ong, H. Karimian, M. Imran, I. Shah, Stimulation of \u03b2-adrenergic receptors plays a protective role via increased expression of RAF-1 and PDX-1 in hyperglycemic rat pancreatic islet (RIN-m5F) cells. Arch Med Sci 13, 470\u2013480 (2017). https:\/\/doi.org\/10.5114\/aoms.2016.64131","journal-title":"Arch Med Sci"},{"key":"3492_CR78","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.bbrc.2015.03.151","volume":"460","author":"K Harada","year":"2015","unstructured":"K. Harada, T. Kitaguchi, T. Tsuboi, Integrative function of adrenaline receptors for glucagon-like peptide-1 exocytosis in enteroendocrine L cell line GLUTag. Biochem Biophys Res Commun 460, 1053\u20131058 (2015). https:\/\/doi.org\/10.1016\/j.bbrc.2015.03.151","journal-title":"Biochem Biophys Res Commun"},{"key":"3492_CR79","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1152\/ajpendo.00197.2004.-Glucagon-like","volume":"287","author":"L Hansen","year":"2004","unstructured":"L. Hansen, S. Lampert, H. Mineo, J.J. Holst, S. Hansen, H. Lampert, J.J. Mineo, Neural regulation of glucagon-like peptide-1 secretion in pigs. Am J Physiol Endocrinol Metab 287, 939\u2013947 (2004). https:\/\/doi.org\/10.1152\/ajpendo.00197.2004.-Glucagon-like","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3492_CR80","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1530\/EC-21-0269","volume":"10","author":"I F\u00f8lling","year":"2021","unstructured":"I. F\u00f8lling, A.B. Wennerstr\u00f8m, T.J. Eide, H.L. Nilsen, Phaeochromocytomas overexpress insulin transcript and produce insulin. Endocr Connect 10, 815\u2013824 (2021). https:\/\/doi.org\/10.1530\/EC-21-0269","journal-title":"Endocr Connect"},{"key":"3492_CR81","doi-asserted-by":"publisher","first-page":"65","DOI":"10.14310\/horm.2002.1224","volume":"8","author":"S Frankton","year":"2009","unstructured":"S. Frankton, S. Baithun, E. Husain, K. Davis, A.B. Grossman, Phaeochromocytoma crisis presenting with profound hypoglycaemia and subsequent hypertension. Hormones. 8, 65\u201370 (2009)","journal-title":"Hormones."},{"key":"3492_CR82","doi-asserted-by":"publisher","first-page":"5153","DOI":"10.3390\/ijms24065153","volume":"24","author":"C Lopez","year":"2023","unstructured":"C. Lopez, C. Bima, M. Bollati, F. Bioletto, M. Procopio, S. Arata, D.G. Candela, G. Beccuti, E. Ghigo, M. Maccario, M. Parasiliti-Caprino, Pathophysiology and management of glycemic alterations before and after surgery for pheochromocytoma and paraganglioma. Int J Mol Sci 24, 5153 (2023). https:\/\/doi.org\/10.3390\/ijms24065153","journal-title":"Int J Mol Sci"},{"key":"3492_CR83","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1097\/HJH.0000000000002438","volume":"38","author":"JWM Lenders","year":"2020","unstructured":"J.W.M. Lenders, M.N. Kerstens, L. Amar, A. Prejbisz, M. Robledo, D. Taieb, K. Pacak, J. Crona, T. Zelinka, M. Mannelli, T. Deutschbein, H.J.L.M. Timmers, F. Castinetti, H. Dralle, J. Widimsk\u00fd, A.P. Gimenez-Roqueplo, G. Eisenhofer, Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. J Hypertens 38, 1443\u20131456 (2020). https:\/\/doi.org\/10.1097\/HJH.0000000000002438","journal-title":"J Hypertens"},{"key":"3492_CR84","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.4158\/EP161210.CR","volume":"3","author":"D Bole","year":"2017","unstructured":"D. Bole, B. Simon, Pheochromocytoma-induced hyperglycemia leading to misdiagnosis of type 1 diabetes mellitus. AACE Clin Case Rep 3, e83\u2013e86 (2017). https:\/\/doi.org\/10.4158\/EP161210.CR","journal-title":"AACE Clin Case Rep"},{"key":"3492_CR85","doi-asserted-by":"publisher","first-page":"R17","DOI":"10.1530\/JME-19-0083","volume":"63","author":"S Thakur","year":"2019","unstructured":"S. Thakur, B. Daley, J. Klubo-Gwiezdzinska, The role of an anti-diabetic drug metformin in the treatment of endocrine tumors. J Mol Endocrinol 63, R17\u2013R35 (2019). https:\/\/doi.org\/10.1530\/JME-19-0083","journal-title":"J Mol Endocrinol"},{"key":"3492_CR86","doi-asserted-by":"publisher","first-page":"384","DOI":"10.2337\/dc22-1148","volume":"46","author":"J Bezin","year":"2023","unstructured":"J. Bezin, A. Gouverneur, M. P\u00e9nichon, C. Mathieu, R. Garrel, D. Hillaire-Buys, A. Pariente, J.-L. Faillie, GLP-1 receptor agonists and the risk of thyroid cancer. Diabetes Care 46, 384\u2013390 (2023). https:\/\/doi.org\/10.2337\/dc22-1148","journal-title":"Diabetes Care"},{"key":"3492_CR87","doi-asserted-by":"publisher","first-page":"5911","DOI":"10.2174\/1381612826666201109110107","volume":"26","author":"G Siasos","year":"2020","unstructured":"G. Siasos, E. Bletsa, P.K. Stampouloglou, S.A. Paschou, E. Oikonomou, V. Tsigkou, A.S. Antonopoulos, M. Vavuranakis, D. Tousoulis, Novel antidiabetic agents: cardiovascular and safety outcomes. Curr Pharm Des 26, 5911\u20135932 (2020). https:\/\/doi.org\/10.2174\/1381612826666201109110107","journal-title":"Curr Pharm Des"},{"key":"3492_CR88","doi-asserted-by":"publisher","first-page":"173141","DOI":"10.1016\/j.ejphar.2020.173141","volume":"879","author":"EC So","year":"2020","unstructured":"E.C. So, P.Y. Liu, S.N. Wu, Effectiveness in the inhibition of dapagliflozin and canagliflozin on M-type K+ current and \u03b1-methylglucoside-induced current in pituitary tumor (GH3) and pheochromocytoma PC12 cells. Eur J Pharmacol 879, 173141 (2020). https:\/\/doi.org\/10.1016\/j.ejphar.2020.173141","journal-title":"Eur J Pharmacol"},{"key":"3492_CR89","doi-asserted-by":"publisher","unstructured":"M. Moustaki, S.A. Paschou, P. Xekouki, K. Kotsa, M. Peppa, T. Psaltopoulou, S. Kalantaridou, A. Vryonidou, A. Secondary diabetes mellitus in acromegaly. Endocrine (2023). https:\/\/doi.org\/10.1007\/s12020-023-03339-1","DOI":"10.1007\/s12020-023-03339-1"},{"key":"3492_CR90","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12020-022-03168-8","volume":"79","author":"M Moustaki","year":"2023","unstructured":"M. Moustaki, S.A. Paschou, E.C. Vakali, A. Vryonidou, Secondary diabetes mellitus due to primary aldosteronism. Endocrine 79, 17\u201330 (2023). https:\/\/doi.org\/10.1007\/s12020-022-03168-8","journal-title":"Endocrine"},{"key":"3492_CR91","doi-asserted-by":"publisher","first-page":"E4028","DOI":"10.1210\/clinem\/dgab401","volume":"106","author":"LN Krumeich","year":"2021","unstructured":"L.N. Krumeich, A.J. Cucchiara, K.L. Nathanson, R.R. Kelz, L. Fishbein, D.L. Fraker, R.E. Roses, D.L. Cohen, H. Wachtel, Correlation between plasma catecholamines, weight, and diabetes in pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 106, E4028\u2013E4038 (2021). https:\/\/doi.org\/10.1210\/clinem\/dgab401","journal-title":"J Clin Endocrinol Metab"},{"key":"3492_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jecr.2018.07.003","volume":"10","author":"J Cha","year":"2018","unstructured":"J. Cha, M. Khurram, L. Gellert, P. Epstein, N. Baregamian, C. Hendrickson, Case of reversible diabetes mellitus in the setting of benign pheochromocytoma. J Clin Transl Endocrinol Case Rep 10, 1\u20133 (2018). https:\/\/doi.org\/10.1016\/j.jecr.2018.07.003","journal-title":"J Clin Transl Endocrinol Case Rep"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03492-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-023-03492-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03492-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T05:15:54Z","timestamp":1698729354000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-023-03492-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,20]]},"references-count":92,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3492"],"URL":"https:\/\/doi.org\/10.1007\/s12020-023-03492-7","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,20]]},"assertion":[{"value":"28 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}